CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that the company’s PurISTSM algorithmic test has received a ...

July 9 (Reuters) - Wall Street brokerages started covering SoftBank Group-backed Tempus AI (TEM.O), opens new tab on a bullish note on Tuesday, betting that the company's AI-powered library of ...

Tempus AI, Inc. is positioned for growth as U.S. pharmaceutical reshoring and regulatory scrutiny increase demand for data-driven healthcare services. Genomics and Data Services segments are ...

CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...

Tempus AI has expanded its relationship with Personalis, investing $36 million in the oncology biotech and becoming the exclusive commercial partner for its test to detect minimal residual disease, or ...

We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other important ...

AI medicine company Tempus released a peak at its 2024 financials during yesterday's J.P. Morgan Healthcare Conference, saying its revenue of about $693 million showed 30% growth year over year and ...

Tempus AI has been publicly traded for only 16 months, and it has been nothing short of a market standout over that time. Compared to its IPO price of $37, Tempus shares were up by a whopping 155% on ...

Investing.com - Stifel maintained its Hold rating and $65.00 price target on Tempus AI Inc (NASDAQ:TEM) following discussions with company management about business trends and key assumptions. The ...